Strides Pharma Science Share Price
1061.60+8.00 (+0.76%)
+18.42% past 1 Year
News
Strides Pharma Science gets USFDA EIR, Bengaluru facility inspection closed with VAI
Equity
STAR
Strides Pharma guides for new product approvals in H2 FY27 pipeline
Equity
STAR
Strides Pharma Science Q1 FY27 revenue flat, eyes stronger H2 launches
Equity
STAR
Strides Pharma Science reports strong Q1 revenue growth on year-on-year basis
Equity
STAR
Strides Pharma Science Q1 EBITDA rises YoY, margin contracts modestly
Equity
STAR
Strides Pharma Science Q1 consolidated net profit rises sharply year-on-year
Equity
STAR
Strides Pharma Science schedules Q1 earnings call on July 31 at 5 PM
Equity
STAR
Strides Pharma sells majority Pivot Path stake to Ascent Capital consortium
Equity
STAR
NCLT approves Strides Pharma spin-off of Arcus Labs life sciences, digital unit
Equity
STAR
Strides Pharma says Sandoz contribution will begin from H2 FY27 onwards
Equity
STAR
Strides Pharma targets Rs 40 crores North America revenue by FY28 outlook update
Equity
STAR
Strides Pharma reports marginal US growth, strong ex-US revenue expansion
Equity
STAR
Strides Pharma board approves Rs 5 per share dividend
Equity
STAR
Strides Pharma Q4 revenue rises year-on-year, indicating healthy topline growth
Equity
STAR
Strides Pharma Q4 EBITDA rises year-on-year; margin slightly moderates
Equity
STAR
Strides Pharma Q4 consolidated net profit rises sharply on year-on-year basis
Equity
STAR
Strides Pharma Science Signs $12M Deal to Acquire Sandoz Generic Brands in Sub-Saharan Africa.
Equity
STAR
Strides Pharma Completes Full Acquisition of Neviton Softech as Wholly Owned Subsidiary
Equity
STAR
Strides Pharma Science Subsidiary Receives USFDA VAI Closure for Chestnut Ridge Facility.
Equity
STAR
Strides Pharma Q3 EBITDA Rises 12% YoY to Rs 236 Crore, Margin Expands to 19.75%.
Equity
STAR